-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials
-
accounts Payable
389,000,000
-
cash Change
8,923,000,000
-
cash Flow
--1,225,000,000
-
cash Flow Financing
--542,000,000
-
changes In Inventories
951,000,000
-
changes In Receivables
1,425,000,000
-
common Stock
386,000,000
-
cost Of Revenue
792,000,000
-
currency
USD
-
current Assets
12,122,000,000
-
current Cash
8,923,000,000
-
current Debt
153,000,000
-
current Long Term Debt
153,000,000
-
depreciation
78,000,000
-
ebit
--366,000,000
-
ebitda
--288,000,000
-
filing Type
10-Q
-
fiscal Date
2023-03-31
-
fiscal Quarter
1
-
fiscal Year
2023
-
goodwill
52,000,000
-
gross Profit
1,070,000,000
-
income Tax
--384,000,000
-
intangible Assets
48,000,000
-
interest Income
--100,000,000
-
inventory
951,000,000
-
long Term Debt
831,000,000
-
long Term Investments
12,003,000,000
-
minority Interest
0
-
net Borrowings
--8,762,000,000
-
net Income
79,000,000
-
net Income Basic
79,000,000
-
net Tangible Assets
18,763,000,000
-
operating Expense
2,228,000,000
-
operating Income
--366,000,000
-
operating Revenue
1,862,000,000
-
other Assets
1,003,000,000
-
other Current Assets
823,000,000
-
other Current Liabilities
2,957,000,000
-
other Income Expense Net
0
-
other Liabilities
836,000,000
-
pretax Income
--305,000,000
-
property Plant Equipment
2,018,000,000
-
receivables
1,425,000,000
-
report Date
2023-05-04
-
research And Development
1,131,000,000
-
retained Earnings
18,399,000,000
-
revenue
1,862,000,000
-
selling General And Admin
305,000,000
-
shareholder Equity
18,863,000,000
-
short Term Debt
153,000,000
-
short Term Investments
823,000,000
-
symbol
MRNA
-
total Assets
24,125,000,000
-
total Cash
8,923,000,000
-
total Debt
984,000,000
-
total Investing Cash Flows
2,011,000,000
-
total Liabilities
5,262,000,000
-
total Revenue
1,862,000,000
-
treasury Stock
0
-
id
FINANCIALS
-
key
MRNA
-
subkey
quarterly
-
date
2023-03-31
-
updated
2023-05-12
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
MRNA stock fundamentals - financials